We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
Cap. Flow
+$552M
Cap. Flow %
5.91%
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.4M
3
INTC icon
Intel
INTC
+$29.2M
4
QCOM icon
Qualcomm
QCOM
+$27.6M
5
DHR icon
Danaher
DHR
+$26M

Top Sells

Rank Stock Value
1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$49.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$41.6M
3
ARQL
Arqule Inc
ARQL
+$26.5M
4
ARWR icon
Arrowhead Research
ARWR
+$24.9M
5
MRK icon
Merck
MRK
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 19.55%
3 Financials 10.18%
4 Consumer Discretionary 9.32%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAX icon
351
Baxter International
BAX
$12.1B
$4.95M 0.05%
59,138
+1,251
+2% +$104K
CSX icon
352
CSX Corp
CSX
$96B
$4.92M 0.05%
203,949
-6,987
-3% -$165K
OC icon
353
Owens Corning
OC
$11.6B
$4.87M 0.05%
74,813
+15,421
+26% +$987K
FISV
354
Fiserv Inc
FISV
$27.9B
$4.84M 0.05%
41,885
-1,884
-4% -$208K
WMT icon
355
Walmart Inc
WMT
$889B
$4.84M 0.05%
122,259
-8,802
-7% -$350K
IOVA icon
356
Iovance Biotherapeutics
IOVA
$2.19B
$4.8M 0.05%
173,478
+103,978
+150% +$2.37M
CF icon
357
CF Industries
CF
$18.4B
$4.78M 0.05%
100,180
+7,636
+8% +$357K
XP icon
358
XP
XP
$8.65B
$4.78M 0.05%
+124,000
New +$4.66M
ALLK
359
DELISTED
Allakos
ALLK
$4.77M 0.05%
+50,000
New +$4.4M
NSC icon
360
Norfolk Southern
NSC
$77.1B
$4.77M 0.05%
24,559
+424
+2% +$79.5K
NOW icon
361
ServiceNow
NOW
$109B
$4.73M 0.05%
83,815
+11,425
+16% +$602K
EIX icon
362
Edison International
EIX
$30.3B
$4.72M 0.05%
62,638
-17,589
-22% -$1.24M
UHS icon
363
Universal Health Services
UHS
$9.64B
$4.72M 0.05%
32,919
-14,358
-30% -$2.05M
WCN
364
Waste Connections
WCN
$42.7B
$4.72M 0.05%
51,951
+26,627
+105% +$2.42M
KGC icon
365
Kinross Gold
KGC
$28.6B
$4.7M 0.05%
989,618
+352,763
+55% +$1.59M
WELL icon
366
Welltower
WELL
$175B
$4.68M 0.05%
57,201
+2,521
+5% +$216K
CNP icon
367
CenterPoint Energy
CNP
$28.8B
$4.67M 0.05%
171,372
-62,082
-27% -$1.69M
RARX
368
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$4.67M 0.05%
99,523
-1,128,477
-92% -$49.9M
LRCX icon
369
Lam Research
LRCX
$365B
$4.64M 0.05%
158,800
+34,910
+28% +$927K
ROST icon
370
Ross Stores
ROST
$78.1B
$4.64M 0.05%
39,864
+2,168
+6% +$244K
BLD
371
DELISTED
TopBuild
BLD
$4.6M 0.05%
44,615
+37,563
+533% +$3.91M
EWC icon
372
iShares MSCI Canada ETF
EWC
$6.13B
$4.6M 0.05%
153,861
-18,764
-11% -$547K
BSX icon
373
Boston Scientific
BSX
$67.6B
$4.59M 0.05%
101,553
-5,464
-5% -$229K
YUMC icon
374
Yum China
YUMC
$15.3B
$4.58M 0.05%
95,470
+22,300
+30% +$991K
PEGI
375
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$4.58M 0.05%
+171,204
New +$4.65M
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2019 Portfolio in Review

As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.

  • Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
  • Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
  • Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
  • Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
  • Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
  • Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.

Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.